Education attenuates the effect of medial temporal lobe atrophy on cognitive function in alzheimer's disease: The mirage study

Journal of Alzheimer's Disease

Volumn 17, Issue 4, 2009, Pages 855-862

  Perneczky, Robert ^a   Wagenpfeil, Stefan ^b   Lunetta, Kathryn L ^c   Cupples, L Adrienne ^c   Green, Robert C ^c,d   Decarli, Charles ^e   Farrer, Lindsay A ^c,d   Kurz, Alexander ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c BOSTON UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Cognition; Cognitive reserve; Dementia; Education; Hippocampus; Magnetic resonance imaging; Medial temporal lobe atrophy

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROVASCULAR DISEASE; COGNITION; DISEASE DURATION; EDUCATION; ETHNICITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUESTIONNAIRE; TEMPORAL LOBE; AGE; ATROPHY; CANADA; CEPHALOMETRY; CLINICAL TRIAL; EDUCATIONAL STATUS; GENETICS; GERMANY; GREECE; MENTAL HEALTH; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POLYMERASE CHAIN REACTION; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; CANADA; CEPHALOMETRY; CEREBROVASCULAR DISORDERS; COGNITION; EDUCATIONAL STATUS; FEMALE; GERMANY; GREECE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TEMPORAL LOBE; TIME FACTORS; UNITED STATES;

EID: 68949146735     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1117     Document Type: Article

References (52)

1. Braak H, Braak E (1996) Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 165, 3-12.
2. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800.
3. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reis-berg B, De Leon MJ, Miller DC (1996) Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging 17, 909-919.
4. Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N,DeCarli C, Chui HC (2008) Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 63, 72-80.
5. Jack CR, Jr., Dickson DW, Parisi JE,Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kok-men E, Petersen RC (2002) Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58, 750-757.
6. De-Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Saint-Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H (2007) Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci 1097, 114-145.
7. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006) Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol 5, 828-834.
8. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72, 491-497.
9. Rothschild D (1934) Alzheimer's disease. A clinicopathologic study of five cases. Am J Psychiatry 91, 485-519.
10. Riley KP, Snowdon DA, Markesbery WR (2002) Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 51, 567-577.
11. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (1988) Clinical, pathological, and neu-rochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23, 138-144.
12. SternY(2002) Whatiscognitivereserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8, 448-460.
13. Mortimer J (2009) Important role of brain reserve in lowering the risk of Alzheimer's disease. Future Neurol 4, 1-4.
14. Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL (2003) Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60, 1909-1915.
15. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell DL, Sackeim HA, Van-Heertum RL, Moeller JR, Stern Y (2003) Association of life activities with cerebral blood flow in Alzheimer's disease. Implications for the cognitive reserve hypothesis. Arch Neurol 60, 359-365.
16. Stern Y, Alexander GE, Prohovnik I, Mayeux R (1992) Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 32, 371-375.
17. Stern Y, Alexander GE, Prohovnik I,StricksL,Link B,Lennon MC, Mayeux R (1995) Relationship between lifetime occupation and parietal flow: Implications for a reserve against Alzheimer's disease pathology. Neurology 45, 55-60.
18. Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, mentis MJ, Shapiro MB (1997) Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 154, 165-172.
19. Perneczky R, Diehl-Schmid J, Förstl H, Drzezga A, Kurz A (2007) Brain reserve capacity in frontotemporal dementia: A voxel-based (18)F-FDG PET study. Eur JNucl Med Mol Imaging 34, 1082-1087.
20. Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A (2007) Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 1133, 178-185.
21. Perneczky R, Drzezga A, Diehl-Schmid J, Schmid G, Wohlschläger A, Kars S, Grimmer T, Wagenpfeil S, Mon-sch A, Kurz A (2006) Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography. J Neurol Neurosurg Pychiatry 77, 1060-1063.
22. Perneczky R, Häussermann P, Diehl-Schmid J, Boecker H, Förstl H, Drzezga A, Kurz A (2007) Metabolic correlates of brain reserve in dementia with Lewy bodies: An FDG PET study. Dement Geriatr Cogn Disord 23, 316-322.
23. Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, Kurz A, Minoshima S, de Leon MJ (2008) Mul-ticenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49, 390-398.
24. Perneczky R, Häussermannn P, Drzezga A, Boecker H, Granert O, Förstl H, Kurz A (2009) Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with lewy bodies: implications for cognitive reserve. Am J Geriatr Psychiatry 17, 188-195.
25. Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, Sorbi S, Cappa SF, Padovani A, Fazio F, Perani D (2008) Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology 71, 1342-1349.
26. Koepsell TD, Kurland BF, Harel O, Johnson EA, Zhou XH, Kukull WA (2008) Education, cognitive function, and severity of neuropathology in Alzheimer disease. Neurology 70, 1732-1739.
27. Stern Y, Zarahn E, Hilton HJ, Flynn J, DeLaPaz R, Rakitin B (2003) Exploring the neural basis of cognitive reserve. J Clin Exp Neuropsychol 25, 691-701.
28. Kidron D, Black SE, Stanchev P, Buck B, Szalai JP, Parker J, Szekely C, Bronskill MJ (1997) Quantitative MR volumetry in Alzheimer's disease. Topographic markers and the effects of sex and education. Neurology 49, 1504-1512.
29. Singer T, Verhaeghen P, Ghisletta P, Lindenberger U, Baltes PB (2003) The fate of cognition in very old age: six-year longitudinal findings in the Berlin Aging Study (BASE). Psychol Aging 18, 318-331.
30. Martins CA, Oulhaj A, de Jager CA, Williams JH (2005) APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology 65, 1888-1893.
31. Witelson SF, Beresh H, Kigar DL (2006) Intelligence and brain size in 100 postmortem brains: sex, lateralization and age factors. Brain 129, 386-398.
32. Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113, 349-388.
33. Swanwick GR, Coen RF, Maguire CP, Kirby M, Walsh JB, O'Neill D, Coakley D, Lawlor BA (1999) The association between demographic factors, disease severity and the duration of symptoms at clinical presentation in elderly people with dementia. Age Ageing 28, 295-299.
34. Demissie S, Green RC, Mucci L, Tziavas S, Martelli K, Bang K, Coons L, Bourque S, Buchillon D, Johnson K, Smith T, Sharrow N, Lautenschlager N, Friedland R, Cupples LA, Farrer LA (2001) Reliability of information collected by proxy in family studies of Alzheimer's disease. Neuroepidemiology 20, 105-111.
35. Farrer LA, Cupples LA, Blackburn S, Kiely DK, Auerbach S, Growdon JH, Connor-Lacke L, Karlinsky H, Thibert A, Burke JR, et al. (1994) Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study. Neurology 44, 652-656.
36. Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R,Burke J,Chui H, Duara R, Foley EJ, Glatt SL, Green RC, Jones R, Karlinsky H, Kukull WA, Kurz A, Larson EB, Martelli K, Sadovnick AD, Volicer L, Waring SC, Growdon JH, Farrer LA (1996) Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 46, 641-650.
37. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
38. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12, 189-198.
39. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A (2006) Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 14, 139-144.
40. Lunetta KL, Erlich PM, Cuenco KT, Cupples LA, Green RC, Farrer LA, Decarli C (2007) Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study. Alzheimer Dis Assoc Disord 21, 85-91.
41. van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR, Jr., DeCarli C (2008) Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol 255, 1302-1308.
42. DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR, Jr., Scheltens P (2007) Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 64, 108-115.
43. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55, 967-972.
44. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242, 557-560.
45. Wahlund LO, Julin P, Lindqvist J, Scheltens P (1999) Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry. Psychiatry Res 90, 193-199.
46. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D'Agostino R, Wolf PA (2005) Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging 26, 491-510.
47. Wu CC, Mungas D,Petkov CI, Eberling JL, Zrelak PA, Buono-core MH, Brunberg JA, Haan MN, Jagust WJ (2002) Brain structure and cognition in a community sample of elderly Latinos. Neurology 59, 383-391.
48. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.
49. Cameron N (1978) The methods of auxological antropometry In Human growth: Vol. 2 Postnatal growth, Falkner F, Tanner J, eds. Plenum press, New York.
50. Perneczky R, Diehl-Schmid J, Drzezga A, Kurz A (2007) Brain reserve capacity in frontotemporal dementia: a voxel- based 18F-FDG PET study. Eur J Nucl Med Mol Imaging 34, 1082-1087.
51. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2005) Education modifies the association of amyloid but not tangles with cognitive function. Neurology 65, 953-955.
52. Bennett DA, Schneider JA, Tang Y, Arnold SE, Wilson RS (2006) The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol 5, 406-412.